Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
KCCC/NGS Laboratory, |
RCV003448499 | SCV004174861 | likely pathogenic | Colorectal cancer, susceptibility to, 12 | 2023-12-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser918*) in the POLE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POLE are known to be pathogenic (PMID: 23230001, 25948378, 30503519). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with POLE-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Therefore, this variant has been classified as Pathogenic. This variant has been confirmed by Sanger sequencing. Pathogenic/likely pathogenic variants in the POLE gene cause susceptibility to colorectal cancer type 12 (OMIM# 615083). |